Can Wolfe’s upgrade push Moderna stock higher?
- Posted on August 26, 2026
- By Business News Today
- 0 Views
- 1 min read
In brief
Generating AI summary…
Can Wolfe’s upgrade push Moderna stock higher?
Shares of Moderna surged again on Tuesday, August 25, after Wolfe Research upgraded the biotech company following encouraging late-stage results for its personalised mRNA cancer vaccine. The stock closed at $158.83, up 14.36% on the day, according to MarketScreener.(Sources: MarketScreener, Reuters) Moderna stock in focus
